Stimulation of Suicidal Erythrocyte Death by Ellipticine

Basic and Clinical Pharmacology and Toxicology

Volumn 116, Issue 6, 2015, Pages 485-492

  Calabrò, Salvatrice ^a,b   Alzoubi, Kousi ^a   Bissinger, Rosi ^a   Faggio, Caterina ^b   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALCIUM; CERAMIDE; DICHLORODIHYDROFLUORESCEIN DIACETATE; ELLIPTICINE; FLUO 3; IONOMYCIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; ELLIPTICINE DERIVATIVE;

ANTIGEN BINDING; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; DRUG EXPOSURE; ERYPTOSIS; ERYTHROCYTE FUNCTION AND CHARACTERISTICS; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; LIGHT SCATTERING; OXIDATIVE STRESS; PRIORITY JOURNAL; BLOOD; CELL DEATH; DRUG EFFECTS; ERYTHROCYTE; IN VITRO STUDY; MEAN CORPUSCULAR VOLUME;

ANNEXIN A5; ANTINEOPLASTIC AGENTS; CALCIUM; CELL DEATH; CERAMIDES; ELLIPTICINES; ERYTHROCYTE INDICES; ERYTHROCYTES; HUMANS; IN VITRO TECHNIQUES; OXIDATIVE STRESS; PHOSPHATIDYLSERINES; REACTIVE OXYGEN SPECIES;

EID: 84928762976     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12350     Document Type: Article

References (109)

1. Stiborova M, Rupertova M, Frei E. Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency. Biochim Biophys Acta 2011;1814:175-85.
2. Fang K, Chen SP, Lin CW, Cheng WC, Huang HT. Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells. Lung Cancer 2009;63:227-34.
3. Hagg M, Berndtsson M, Mandic A, Zhou R, Shoshan MC, Linder S. Induction of endoplasmic reticulum stress by ellipticine plant alkaloids. Mol Cancer Ther 2004;3:489-97.
4. Kim JY, Lee SG, Chung JY, Kim YJ, Park JE, Koh H et al. Ellipticine induces apoptosis in human endometrial cancer cells: the potential involvement of reactive oxygen species and mitogen-activated protein kinases. Toxicology 2011;289:91-102.
5. Kuo PL, Hsu YL, Chang CH, Lin CC. The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells. Cancer Lett 2005;223:293-301.
6. Kuo PL, Hsu YL, Kuo YC, Chang CH, Lin CC. The anti-proliferative inhibition of ellipticine in human breast mda-mb-231 cancer cells is through cell cycle arrest and apoptosis induction. Anticancer Drugs 2005;16:789-95.
7. Kuo YC, Kuo PL, Hsu YL, Cho CY, Lin CC. Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. Life Sci 2006;78:2550-7.
8. Prochazka P, Libra A, Zemanova Z, Hrebackova J, Poljakova J, Hrabeta J et al. Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells. Cancer Sci 2012;103:334-41.
9. Savorani C, Manfe V, Biskup E, Gniadecki R. Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage. Leuk Lymphoma 2014. doi: 10.3109/10428194.2014.929673:1-9. [Epub ahead of print].
10. Peng Y, Li C, Chen L, Sebti S, Chen J. Rescue of mutant p53 transcription function by ellipticine. Oncogene 2003;22:4478-87.
11. Xu GW, Mawji IA, Macrae CJ, Koch CA, Datti A, Wrana JL et al. A high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization. Apoptosis 2008;13:413-22.
12. Wang F, Liu J, Robbins D, Morris K, Sit A, Liu YY et al. Mutant p53 exhibits trivial effects on mitochondrial functions which can be reactivated by ellipticine in lymphoma cells. Apoptosis 2011;16:301-10.
13. Garbett NC, Graves DE. Extending nature's leads: the anticancer agent ellipticine. Curr Med Chem Anticancer Agents 2004;4:149-72.
14. Poljakova J, Eckschlager T, Hrabeta J, Hrebackova J, Smutny S, Frei E et al. The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells. Biochem Pharmacol 2009;77:1466-79.
15. Stiborova M, Rupertova M, Schmeiser HH, Frei E. Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006;150:13-23.
16. Lang E, Qadri SM, Lang F. Killing me softly - suicidal erythrocyte death. Int J Biochem Cell Biol 2012;44:1236-43.
17. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-60.
18. Abed M, Towhid ST, Mia S, Pakladok T, Alesutan I, Borst O et al. Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 2012;303:C991-9.
19. Bhavsar SK, Bobbala D, Xuan NT, Foller M, Lang F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol Biochem 2010;26:859-68.
20. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M et al. Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci USA 2008;105:6771-6.
21. Foller M, Mahmud H, Gu S, Wang K, Floride E, Kucherenko Y et al. Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death. J Physiol Pharmacol 2009;60:135-43.
22. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP et al. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012;6:847-56.
23. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2013;50:489-95.
24. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-80.
25. Kucherenko Y, Zelenak C, Eberhard M, Qadri SM, Lang F. Effect of casein kinase 1alpha activator pyrvinium pamoate on erythrocyte ion channels. Cell Physiol Biochem 2012;30:407-17.
26. Zelenak C, Eberhard M, Jilani K, Qadri SM, Macek B, Lang F. Protein kinase CK1alpha regulates erythrocyte survival. Cell Physiol Biochem 2012;29:171-80.
27. Bhavsar SK, Gu S, Bobbala D, Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011;27:547-56.
28. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006;290:C244-53.
29. Gatidis S, Zelenak C, Fajol A, Lang E, Jilani K, Michael D et al. p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011;28:1279-86.
30. Zelenak C, Foller M, Velic A, Krug K, Qadri SM, Viollet B et al. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J Proteome Res 2011;10:1690-7.
31. Lupescu A, Jilani K, Zelenak C, Zbidah M, Qadri SM, Lang F. Hexavalent chromium-induced erythrocyte membrane phospholipid asymmetry. Biometals 2012;25:309-18.
32. Shaik N, Lupescu A, Lang F. Sunitinib-sensitive suicidal erythrocyte death. Cell Physiol Biochem 2012;30:512-22.
33. Abed M, Towhid ST, Shaik N, Lang F. Stimulation of suicidal death of erythrocytes by rifampicin. Toxicology 2012;302:123-8.
34. Bottger E, Multhoff G, Kun JF, Esen M. Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70. PLoS ONE 2012;7:e33774.
35. Firat U, Kaya S, Cim A, Buyukbayram H, Gokalp O, Dal MS et al. Increased caspase-3 immunoreactivity of erythrocytes in STZ diabetic rats. Exp Diabetes Res 2012;2012:316384.
36. Ganesan S, Chaurasiya ND, Sahu R, Walker LA, Tekwani BL. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway. Toxicology 2012;294:54-60.
37. Gao M, Cheung KL, Lau IP, Yu WS, Fung KP, Yu B et al. Polyphyllin D induces apoptosis in human erythrocytes through Ca(2)(+) rise and membrane permeabilization. Arch Toxicol 2012;86:741-52.
38. Ghashghaeinia M, Cluitmans JC, Akel A, Dreischer P, Toulany M, Koberle M et al. The impact of erythrocyte age on eryptosis. Br J Haematol 2012;157:606-14.
39. Jilani K, Lupescu A, Zbidah M, Abed M, Shaik N, Lang F. Enhanced apoptotic death of erythrocytes induced by the mycotoxin ochratoxin A. Kidney Blood Press Res 2012;36:107-18.
40. Jilani K, Qadri SM, Lang F. Geldanamycin-induced phosphatidylserine translocation in the erythrocyte membrane. Cell Physiol Biochem 2013;32:1600-9.
41. Kucherenko YV, Lang F. Inhibitory effect of furosemide on non-selective voltage-independent cation channels in human erythrocytes. Cell Physiol Biochem 2012;30:863-75.
42. Lupescu A, Jilani K, Zbidah M, Lang E, Lang F. Enhanced Ca(2+) entry, ceramide formation, and apoptotic death of erythrocytes triggered by plumbagin. J Nat Prod 2012;75:1956-61.
43. Lupescu A, Jilani K, Zbidah M, Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology 2012;300:132-7.
44. Polak-Jonkisz D, Purzyc L. Ca influx versus efflux during eryptosis in uremic erythrocytes. Blood Purif 2012;34:209-10.
45. Qian EW, Ge DT, Kong SK. Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J Nat Prod 2012;75:531-7.
46. Shaik N, Zbidah M, Lang F. Inhibition of Ca(2+) entry and suicidal erythrocyte death by naringin. Cell Physiol Biochem 2012;30:678-86.
47. Vota DM, Maltaneri RE, Wenker SD, Nesse AB, Vittori DC. Differential erythropoietin action upon cells induced to eryptosis by different agents. Cell Biochem Biophys 2013;65:145-57.
48. Weiss E, Cytlak UM, Rees DC, Osei A, Gibson JS. Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 2012;51:51-6.
49. 2 increases? J Cardiometab Syndr 2008;3:30-4.
50. Zbidah M, Lupescu A, Jilani K, Lang F. Stimulation of suicidal erythrocyte death by fumagillin. Basic Clin Pharmacol Toxicol 2013;112:346-51.
51. Zbidah M, Lupescu A, Shaik N, Lang F. Gossypol-induced suicidal erythrocyte death. Toxicology 2012;302:101-5.
52. Zelenak C, Pasham V, Jilani K, Tripodi PM, Rosaclerio L, Pathare G et al. Tanshinone IIA stimulates erythrocyte phosphatidylserine exposure. Cell Physiol Biochem 2012;30:282-94.
53. Abed M, Herrmann T, Alzoubi K, Pakladok T, Lang F. Tannic acid induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:1106-16.
54. Ahmed MS, Langer H, Abed M, Voelkl J, Lang F. The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 2013;37:158-67.
55. Ghashghaeinia M, Cluitmans JC, Toulany M, Saki M, Koberle M, Lang E et al. Age sensitivity of NFkappaB abundance and programmed cell death in erythrocytes induced by NFkappaB inhibitors. Cell Physiol Biochem 2013;32:801-13.
56. Abed M, Feger M, Alzoubi K, Pakladok T, Frauenfeld L, Geiger C et al. Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res 2013;37:567-78.
57. Alzoubi K, Honisch S, Abed M, Lang F. Triggering of suicidal erythrocyte death by Penta-O-galloyl-beta-d-glucose. Toxins (Basel) 2014;6:54-65.
58. Jilani K, Enkel S, Bissinger R, Almilaji A, Abed M, Lang F. Fluoxetine induced suicidal erythrocyte death. Toxins (Basel) 2013;5:1230-43.
59. Lupescu A, Bissinger R, Jilani K, Lang F. Triggering of suicidal erythrocyte death by celecoxib. Toxins (Basel) 2013;5:1543-54.
60. Lupescu A, Jilani K, Zbidah M, Lang F. Patulin-induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:291-9.
61. Lang E, Qadri SM, Jilani K, Zelenak C, Lupescu A, Schleicher E et al. Carbon monoxide-sensitive apoptotic death of erythrocytes. Basic Clin Pharmacol Toxicol 2012;111:348-55.
62. Abed M, Zoubi KA, Theurer M, Lang F. Effect of dermaseptin on erythrocytes. Basic Clin Pharmacol Toxicol 2013;113:347-52.
63. Arnold M, Lang E, Modicano P, Bissinger R, Faggio C, Abed M et al. Effect of nitazoxanide on erythrocytes. Basic Clin Pharmacol Toxicol 2014;114:421-6.
64. Oswald G, Alzoubi K, Abed M, Lang F. Stimulation of suicidal erythrocyte death by ribavirin. Basic Clin Pharmacol Toxicol 2014;114:311-7.
65. Bissinger R, Malik A, Jilani K, Lang F. Triggering of erythrocyte cell membrane scrambling by salinomycin. Basic Clin Pharmacol Toxicol 2014. doi: 10.1111/bcpt.12250. [Epub ahead of print].
66. Zbidah M, Lupescu A, Jilani K, Fajol A, Michael D, Qadri SM et al. Apigenin-induced suicidal erythrocyte death. J Agric Food Chem 2012;60:533-8.
67. Bentzen PJ, Lang E, Lang F. Curcumin induced suicidal erythrocyte death. Cell Physiol Biochem 2007;19:153-64.
68. Lupescu A, Jilani K, Zelenak C, Zbidah M, Shaik N, Lang F. Induction of programmed erythrocyte death by gambogic acid. Cell Physiol Biochem 2012;30:428-38.
69. Zbidah M, Lupescu A, Herrmann T, Yang W, Foller M, Jilani K et al. Effect of honokiol on erythrocytes. Toxicol In Vitro 2013;27:1737-45.
70. Shaik N, Alhourani E, Bosc A, Liu G, Towhid S, Lupescu A et al. Stimulation of suicidal erythrocyte death by ipratropium bromide. Cell Physiol Biochem 2012;30:1517-25.
71. Jilani K, Qadri SM, Zelenak C, Lang F. Stimulation of suicidal erythrocyte death by oridonin. Arch Biochem Biophys 2011;511:14-20.
72. Bissinger R, Modicano P, Alzoubi K, Honisch S, Faggio C, Abed M et al. Effect of saponin on erythrocytes. Int J Hematol 2014;100:51-9.
73. Qadri SM, Mahmud H, Foller M, Lang F. Thymoquinone-induced suicidal erythrocyte death. Food Chem Toxicol 2009;47:1545-9.
74. Jilani K, Abed M, Zelenak C, Lang E, Qadri SM, Lang F. Triggering of erythrocyte cell membrane scrambling by ursolic acid. J Nat Prod 2011;74:2181-6.
75. Jilani K, Lupescu A, Zbidah M, Shaik N, Lang F. Withaferin A-stimulated Ca2+ entry, ceramide formation and suicidal death of erythrocytes. Toxicol In Vitro 2013;27:52-8.
76. Sinha A, Singh A, Satchidanandam V, Natarajan K. Impaired generation of reactive oxygen species during differentiation of dendritic cells (DCs) by Mycobacterium tuberculosis secretory antigen (MTSA) and subsequent activation of MTSA-DCs by mycobacteria results in increased intracellular survival. J Immunol 2006;177:468-78.
77. Wu Y, Sadatmousavi P, Wang R, Lu S, Yuan YF, Chen P. Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo. Int J Nanomedicine 2012;7:3221-33.
78. Harrison HE, Bunting H, Ordway NK, Albrink WS. The pathogenesis of the renal injury produced in the dog by hemoglobin or methemoglobin. J Exp Med 1947;86:339-56.
79. Foller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F. Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 2009;24:133-40.
80. Duranton C, Huber S, Tanneur V, Lang K, Brand V, Sandu C et al. Electrophysiological properties of the Plasmodium falciparum-induced cation conductance of human erythrocytes. Cell Physiol Biochem 2003;13:189-98.
81. Kirk K. Membrane transport in the malaria-infected erythrocyte. Physiol Rev 2001;81:495-537.
82. Ayi K, Giribaldi G, Skorokhod A, Schwarzer E, Prendergast PT, Arese P. 16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity. Antimicrob Agents Chemother 2002;46:3180-4.
83. Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: a common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004;104:3364-71.
84. Cappadoro M, Giribaldi G, O'Brien E, Turrini F, Mannu F, Ulliers D et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998;92:2527-34.
85. Koka S, Foller M, Lamprecht G, Boini KM, Lang C, Huber SM et al. Iron deficiency influences the course of malaria in Plasmodium berghei infected mice. Biochem Biophys Res Commun 2007;357:608-14.
86. Koka S, Huber SM, Boini KM, Lang C, Foller M, Lang F. Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice. Biochem Biophys Res Commun 2007;363:484-9.
87. Koka S, Lang C, Boini KM, Bobbala D, Huber SM, Lang F. Influence of chlorpromazine on eryptosis, parasitemia and survival of Plasmodium berghe infected mice. Cell Physiol Biochem 2008;22:261-8.
88. Koka S, Lang C, Niemoeller OM, Boini KM, Nicolay JP, Huber SM et al. Influence of NO synthase inhibitor L-NAME on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2008;21:481-8.
89. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-70.
90. Lang E, Gatidis S, Freise NF, Bock H, Kubitz R, Lauermann C et al. Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 2014. doi: 10.1002/hep.27338. [Epub ahead of print].
91. Qadri SM, Mahmud H, Lang E, Gu S, Bobbala D, Zelenak C et al. Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med 2012;16:1085-93.
92. Calderon-Salinas JV, Munoz-Reyes EG, Guerrero-Romero JF, Rodriguez-Moran M, Bracho-Riquelme RL, Carrera-Gracia MA et al. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol Cell Biochem 2011;357:171-9.
93. Abed M, Artunc F, Alzoubi K, Honisch S, Baumann D, Foller M et al. Suicidal erythrocyte death in end-stage renal disease. J Mol Med (Berl) 2014;92:871-9.
94. Voelkl J, Alzoubi K, Mamar AK, Ahmed MS, Abed M, Lang F. Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations. Kidney Blood Press Res 2013;38:42-51.
95. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C et al. Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004;448:471-7.
96. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med (Berl) 2006;84:378-88.
97. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J et al. Suicidal erythrocyte death in sepsis. J Mol Med (Berl) 2007;85:273-81.
98. Foller M, Braun M, Qadri SM, Lang E, Mahmud H, Lang F. Temperature sensitivity of suicidal erythrocyte death. Eur J Clin Invest 2010;40:534-40.
99. Totino PR, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F. Refractoriness of eryptotic red blood cells to Plasmodium falciparum infection: a putative host defense mechanism limiting parasitaemia. PLoS ONE 2011;6:e26575.
100. Basu S, Banerjee D, Chandra S, Chakrabarti A. Eryptosis in hereditary spherocytosis and thalassemia: role of glycoconjugates. Glycoconj J 2010;27:717-22.
101. Ibrahim HA, Fouda MI, Yahya RS, Abousamra NK, Abd Elazim RA. Erythrocyte phosphatidylserine exposure in beta-thalassemia. Lab Hematol 2014;20:9-14.
102. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007;13:164-70.
103. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82.
104. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-21.
105. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-88.
106. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-2.
107. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD et al. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-7.
108. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L et al. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709.
109. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-80.